Oral Answers to Questions

Phillip Lee Excerpts

Wednesday 16th January 2019 Commons Chamber

[The Prime Minister]

This is an important issue that has been raised by a number of Members from across the House. Our priority is always the safety of patients. Ministers are aware of the new study that has come out. We have a commitment to review any new evidence in this area, and we do that, but we do it by consulting independent scientific experts. Baroness Cumberledge is leading the independent medicines and medical devices safety review. That is expected to examine what happened in the case of Primodos and will determine what further action is needed. I assure the hon. Lady that we will listen very carefully to any recommendations that come out of the review, and of course that study will be looked at very carefully to see what has come out of it.

[Dr Phillip Lee (Bracknell) (Con)]

Does my right hon. Friend recognise, particularly since last night, that in these complex circumstances, her role as Prime Minister is now to create the political environment in which solutions to the Brexit conundrum can be found and not to continue with a plan expecting a different outcome? Does she also accept, then, that if she cannot get what she wants, she will need to change her mind to secure public confidence?

[The Prime Minister]

As I have pointed out today and as I said last night, it is precisely because we recognise the need to understand rather better what can command and secure the support of the House that we will be talking to parliamentarians across the House, and that includes my right hon. and hon. Friends, the Democratic Unionist party and parliamentarians across other parties. That is because, as my right hon. and learned Friend the Member for Rushcliffe (Mr Clarke) said, there is quite a variety of views across the House about what is right.